- /
- Supported exchanges
- / US
- / CRBP.NASDAQ
Corbus Pharmaceuticals Holding (CRBP NASDAQ) stock market data APIs
Corbus Pharmaceuticals Holding Financial Data Overview
Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, develops products to defeat serious illness. It develops CRB-701, an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E (MMAE), which is in Phase I clinical trial; CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFß expressed on cancer cells for the treatment of solid tumors; CRB-913, a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has a licensing agreement with Jenrin Discovery, LLC to develop and commercialize the licensed products, including the Jenrin library of approximately 600 compounds, and multiple issued and pending patent filings. The company was incorporated in 2009 and is based in Norwood, Massachusetts.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Corbus Pharmaceuticals Holding (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Corbus Pharmaceuticals Holding data using free add-ons & libraries
Get Corbus Pharmaceuticals Holding Fundamental Data
Corbus Pharmaceuticals Holding Fundamental data includes:
- Net Revenue:
- EBITDA: -75 631 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-11-12
- EPS/Forecast: -1.707
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Corbus Pharmaceuticals Holding News
New
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers
(RTTNews) - Several small-cap biotech and healthcare names posted notable gains in Thursday's after-hours trading session, with investors reacting to recent corporate updates and clinical milestones. ...
Stocks making the biggest moves midday: Oracle, Vail Resorts, GE Vernova, Brinks, Ciena & more
Check out the companies making the biggest moves midday: Oracle — The database management software maker tumbled 14% after reporting fiscal second-quarter revenue that missed analyst expectations. M...
Corbus Reports Positive Phase 1a Results Of CRB-913 In Obesity, Stock Surges - Update
(RTTNews) - Corbus Pharmaceuticals Holdings Inc. (CRBP) has announced favorable results from its Phase 1a study of CRB-913, an oral CB1 inverse agonist being developed for chronic obesity management. ...
Stocks making the biggest moves premarket: Oracle, Oxford Industries, Adobe, Gemini Space Station & more
Check out the companies making headlines before the bell: Oracle — The software giant tumbled more than 12% after reporting fiscal second-quarter revenue that missed analyst expectations. Analysts a...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.